ClinicalTrials.Veeva

Menu
I

Intrepid Research | Cincinnati, OH

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pitolisant
TAK-861
JZP-258
TAK-994
Lorundrostat
Atomoxetine
IHL-42X
AD504
Lemborexant
Acetazolamide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 38 total trials

A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH (XYRISE)

The purpose of this study is to evaluate the efficacy and safety of expanded Xywav dosing regimens in adult participants with narcolepsy or idiopathi...

Begins enrollment this month
Idiopathic Hypersomnia
Narcolepsy
Drug: Xywav
Other: Placebo

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Retatrutide

The main aim is to evaluate the safety and tolerability of TAK-861 in participants with type 1 narcolepsy, who were exposed to previously tested dose...

Enrolling
Narcolepsy Type 1
Drug: TAK-861

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only
OSA
Drug: Aroxybutynin and Atomoxetine

The goal of this randomized, double-blind, multi-dose crossover clinical trial is to determine the safety and efficacy of IHL-42X in subjects with ob...

Not yet enrolling
Obstructive Sleep Apnea (OSA)
Drug: Placebo: Negative control
Drug: IHL-42X: 2.5 mg dronabinol + 125 mg acetazolamide

This study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with hypert...

Active, not recruiting
Hypertension
Drug: lorundrostat
Drug: Placebo

The goal of this randomised, double-blind phase II/III clinical trial is to determine the safety and efficacy of IHL-42X in subjects with obstructive...

Active, not recruiting
Obstructive Sleep Apnea
Drug: Acetazolamide
Drug: IHL-42X Low Dose

The primary purpose of this study is to evaluate the effectiveness of sivopixant, acetazolamide and SASS-001 in adults with sleep apnea with a centra...

Active, not recruiting
Sleep Apnea
Drug: SASS-001
Drug: Placebo

Trial sponsors

Jazz Pharmaceuticals logo
Takeda logo
Apnimed logo
Eisai logo
H
I
M
N
Axsome Therapeutics logo
B

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems